BiotechTube
Home/ReproNovo/Bingmei Hao
BH

Bingmei Hao

Chief Financial Officer

ReproNovo

Therapeutic Areas

Reproductive MedicineWomen's Health

ReproNovo Pipeline

DrugIndicationPhase
RPN-001 (leflutrozole)Male Infertility (Hypogonadism)Phase 2
Unnamed ProgramManagement of AdenomyosisNot Disclosed

Leadership Team at ReproNovo

JM
Jean Marie Duvall
Chief Executive Officer
JA
Joan-Carles Arce, MD PhD
Chief Scientific & Medical Officer
MA
Mark Altmeyer
Chairman of the Board
View full ReproNovo profile